Sonnet BioTherapeutic News

Sonnet BioTherapeutic | DEF 14A: Definitive information statements

Aug 19 17:28 ET

Sonnet BioTherapeutic | 8-K: Current report

Aug 19 08:52 ET

Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Aug 14 08:44 ET

Sonnet BioTherapeutic | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Aug 9 17:33 ET

Sonnet BioTherapeutic | 8-K: Current report

Aug 9 16:08 ET

Sonnet BioTherapeutic | 8-K: Current report

Jul 24 08:39 ET

Sonnet BioTherapeutic | S-3: Registration statement for specified transactions by certain issuers

Jul 5 16:08 ET

Sonnet BioTherapeutic | 8-K: Current report

Jun 20 16:52 ET

Sonnet BioTherapeutic | 8-K: Current report

Jun 14 12:47 ET

Sonnet BioTherapeutic | 8-K: Current report

Jun 13 08:18 ET

Sonnet BioTherapeutic | 8-K: Current report

May 22 07:39 ET

Sonnet BioTherapeutic | 8-K: Current report

May 20 09:30 ET

Sonnet BioTherapeutic | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

May 15 17:10 ET

Sonnet BioTherapeutic | 8-K: Current report

May 14 17:30 ET

Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Provides Fiscal Year 2024 Second Quarter and Year-to-Date Business and Earnings Update

May 14 17:11 ET

Sonnet BioTherapeutic | S-1: General form for registration of securities under the Securities Act of 1933

May 3 08:36 ET

Sonnet BioTherapeutic | 8-K: Current report

May 3 08:06 ET

Sonnet BioTherapeutic | 8-K: Current report

Mar 11 07:31 ET

Sonnet BioTherapeutic | 8-K: Current report

Mar 6 16:28 ET

Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update

Feb 14 07:37 ET